Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancers Lymphatic”

19,877 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 19,877 results

Testing effectiveness (Phase 2)Looking for participantsNCT03128034
What this trial is testing

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia+9 more
Fred Hutchinson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Early research (Phase 1)Study completedNCT03042793
What this trial is testing

Vaccination With PD-L1 Peptide Against Multiple Myeloma

Who this might be right for
Multiple Myeloma
Lene Meldgaard Knudsen 10
Not applicableStudy completedNCT02192333
What this trial is testing

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Who this might be right for
Breast CarcinomaCancer SurvivorDepression+10 more
Fred Hutchinson Cancer Center 390
Not applicableStudy completedNCT02662933
What this trial is testing

Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)

Who this might be right for
ACUTE MYELOGENOUS LEUKEMIA
Wake Forest University Health Sciences 82
Very early researchLooking for participantsNCT06385652
What this trial is testing

PET Imaging Study of 68Ga-NB381 in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Peking University First Hospital 30
Early research (Phase 1)Study completedNCT05321147
What this trial is testing

Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2

Who this might be right for
Peripheral T Cell Lymphoma
Innate Pharma 20
Early research (Phase 1)Study completedNCT00938626
What this trial is testing

Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 12
Not applicableStudy completedNCT04703985
What this trial is testing

Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of Autologous Hematopoietic Cells in Hematology

Who this might be right for
LymphomaMyeloma
University Hospital, Bordeaux 200
Early research (Phase 1)Study completedNCT00569985
What this trial is testing

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT00494585
What this trial is testing

CEP-701 for PH-negative Myelofibrosis

Who this might be right for
LeukemiaMyelofibrosis
M.D. Anderson Cancer Center 27
Very early researchStudy completedNCT01184885
What this trial is testing

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Who this might be right for
Lymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 7
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Early research (Phase 1)Ended earlyNCT01957644
What this trial is testing

Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Study completedNCT00168064
What this trial is testing

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Yaupon Therapeutics 260
Testing effectiveness (Phase 2)Study completedNCT00566098
What this trial is testing

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Looking for participantsNCT05463263
What this trial is testing

STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Who this might be right for
Lymphoma, B-CellLymphoma, T-Cell
Step Pharma, SAS 180
Not applicableUnknownNCT04970316
What this trial is testing

Late Organ Specific Adverse Effects hiPec or pElvic eXenteration

Who this might be right for
Colorectal Cancer
University of Aarhus 225
Early research (Phase 1)Ended earlyNCT01534949
What this trial is testing

Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial

Who this might be right for
Diffuse Large B-Cell Lymphoma
Celltrion 1
Not applicableStudy completedNCT04788758
What this trial is testing

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 76
Load More Results